Heparin
Links shared publicly online about this topic
Heparin standards
theheart.org — “The Food and Drug Administration is asking clinicians to be aware of the change, particularly in settings where an immediate anticoagulant effect is clinically important.” View full resource at theheart.org
Most Recently Shared on October 2, 2009 at 5:15 pm By:
heartwire: New heparin standards reduce potency of drug 10% http://bit.ly/1Cm0B7
Symposier - Heparin
symposier.com — “Uploaded and Shared in Youtube by:sivsorg FDA on Heparin” View full resource at symposier.com
Most Recently Shared on December 2, 2009 at 4:27 pm By:
Symposier Cardiology Cardiology and Health Business
Good morning everyone!! FDA Report on Heparin(injectable anticoagulant) -->http://bit.ly/6OYKQH // Shared at Symposier site
Heparin: Change in Reference Standard
fda.gov — “New studies reinforce FDA's previous recommendation for healthcare professionals to exercise clinical judgment in determining the dose of heparin for a patient.” View full resource at fda.gov
Most Recently Shared on October 1, 2009 at 7:36 pm By:
Physician Assistants Health News Feed
FDA notified healthcare professionals and patients of a change to heparin: http://tinyurl.com/y9lmvyb
FDA faulted in heparin contamination
theheart.org — “The investigation uncovered new information that warrants further review of Chongqing Imperial for direct involvement in, or knowledge about, the contamination of heparin.” View full resource at theheart.org
Most Recently Shared on May 3, 2010 at 1:25 pm By:
Congressional investigation slams FDA over heparin contamination: The investigation uncovered new information that... http://bit.ly/aK6JIa
Symposier - Important Changes for Heparin
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is notifying healthcare professionals and patients about a new USP monograph for heparin. Under the new monograph, the reference standard used to determine the potency of the drug will be changed in order to make it compatible with the WHO International Standard. Despite these changes in the reference standard, heparin dosages will continue to be expressed in USP units. Partly in response to the recent heparin contamination proble” View full resource at symposier.com
Most Recently Shared on December 11, 2009 at 6:04 pm By:
Symposier Cardiology Cardiology and Health Business
FDA: New USP monograph for Heparin(injectable anticoagulant) -->http://bit.ly/5q8xnA
Heparin may cause skin lesions
healthcentral.com — “Heparin may cause skin lesions” View full resource at healthcentral.com
Most Recently Shared on September 30, 2009 at 3:54 pm By:
healthcentral: Heparin may cause skin lesions http://bit.ly/JoHJY Full http://bit.ly/4h6Ntv
Heparin Can Cause Skin Lesions
medicalnewstoday.com — “Heparin, a commonly used anticoagulant, can cause skin lesions, reports a study http://www.cmaj.ca/press/cmaj081729” View full resource at medicalnewstoday.com
Most Recently Shared on September 29, 2009 at 6:40 pm By:
MNT Dermatology News Dermatology and Health News
Heparin Can Cause Skin Lesions: Heparin, a commonly used anticoagulant, can cause skin lesions, reports a study.. http://bit.ly/3S4LOm
Cardiology Medical News about Heparin
mdlinx.com — “Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality” View full resource at mdlinx.com
Most Recently Shared on January 7, 2010 at 9:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Morta http://url4.eu/14G8V
Cardiology Medical News about Heparin
mdlinx.com — “Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention. Results of the Phase 2 Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial” View full resource at mdlinx.com
Most Recently Shared on April 7, 2010 at 9:51 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention. Results of the Phase 2 Eva... http://bit.ly/90vKBD #cardio #mdlinx
Cardiology Medical News about Heparin
mdlinx.com — “Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 2:59 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Post-operative heparin may not be required for transitioning patients with a HeartMate II left vent... http://bit.ly/aNmyTO #cardio #mdlinx
Surgery Medical News about Heparin
mdlinx.com — “Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 2:53 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular as... http://bit.ly/bhBmjw #SURG
FDA Alert: Heparin: Change in Reference Standard
drugs.com — “FDA Alert: Heparin: Change in Reference Standard” View full resource at drugs.com
Most Recently Shared on April 7, 2010 at 9:12 pm By:
FDA Alert - Heparin: Change in Reference Standard - http://bit.ly/9z9WIR
FDA Alert: Heparin: Change in Reference Standard
drugs.com — “FDA Alert: Heparin: Change in Reference Standard” View full resource at drugs.com
Most Recently Shared on October 1, 2009 at 11:07 pm By:
FDA Alert - FDA Announces Change in USP Reference Standard for Heparin - http://bit.ly/2Xwhin
FDA chief defends handling of heparin, Momenta | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration had to act swiftly during a massive recall of the widely-used blood thinner heparin, but was not influenced by help from Momenta Pharmaceuticals” View full resource at reuters.com
Most Recently Shared on November 10, 2010 at 2:15 am By:
Hisham Rana, MD Doctor and Physician
News: FDA chief defends handling of heparin, Momenta http://reut.rs/dCepI1 - #health
FDA chief defends handling of heparin, Momenta | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration had to act swiftly during a massive recall of the widely-used blood thinner heparin, but was not influenced by help from Momenta Pharmaceuticals” View full resource at reuters.com
Most Recently Shared on November 9, 2010 at 10:32 pm By:
FDA chief defends handling of heparin, Momenta http://dlvr.it/8HPnD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Physician Assistants
- Physician Assistants (P.A.) are licensed health professionals who practice medicine with the supervision of a physician
Advertisement
